It is understood that Vitamin D is vital to one’s overall health. Sun exposure is known to be its natural benefactor, but it can also be acquired through our food choices such as fatty fishes (like salmon and trout), and in food supplements. It’s a nutrient that’s pretty easy to obtain.
However, certain of groups of people are more prone to Vitamin D deficiency, including adults over the age of 55 and dark-skinned people . Vitamin D deficiency can lead to serious implications to one’s body–most especially to our bones. Rickets is the disease associated with Vitamin D deficiency; it occurs when the bone tissue doesn’t mineralize properly, resulting in soft bones and deformities in the skeletal system. Worse, a serious lack of the so-called ‘sunshine vitamin’ could be one of the many agents of cancer.
But like a light at the end of a tunnel, research can now provide evidence that consuming vitamin D has the power to not only dodge but decrease the risk of breast cancer with researchers hailing from the USA and Europe backing these revelations.
Researchers from the University of California San Diego School of Medicine have published this discovery on the June 15 issue of PLoS One in collaboration with Creighton University, Medical University of South Carolina, and GrassRootsHealth.
Principal investigator Cedric E. Garland and his team underwent an analysis of two clinical trials conducted between 2002 and 2017 with a total of 3,325 participants all comprising of women aged 63 years old. It revealed that people with higher blood concentration of Vitamin D biomarker have been exposed to a significantly lower risk of breast cancer.
On the other side of the globe, Irish researchers have also suggested that there could be a 20% increase in survival for patients who took Vitamin D supplements as compared to those who did not. The study was conducted and led by Dr. Jamie Madden from the Royal College of Surgeons in Ireland (RCSI) and the Irish Cancer Society (ICS), who analyzed 5,500 breast cancer patients between 50 and 80 between 2000 and 2011.
However, Dr. Robert O’Connor, head researcher of ICS said that they will only distinguish if Vitamin D supplementation should be recommended to improve breast cancer treatment in the coming years when clinical trials emerge.
Regardless, dietary and lifestyle choices are still highly essential factors. Hence, Proventa International’s 7th Oncology Strategy Meeting is set to discuss these biomarker discoveries with executives from top pharmaceutical companies. Click here to know more about Proventa International’s unique format.
By Audrey Mari Vibar
Content Strategist, Proventa International